Stay informed about the latest diabetes news and research, including medical discoveries, treatment developments, clinical studies, technology and emerging health insights.
Research led by Hebrew University suggests that eating with others not only enhances meal enjoyment but also improves blood sugar control and other vital bodily functions, highlighting complex links between social connection and health. Eating with other people may do…
As GLP-1 medications become a common treatment for weight loss and diabetes, experts highlight promising benefits but warn of unresolved safety concerns, especially around long-term use and discontinuation risks amid rising costs and access challenges. GLP-1 medicines are moving from…
A new review highlights promising results for platelet-rich plasma as an adjunct therapy for diabetic foot ulcers, yet underscores the need for standardised research to confirm its long-term safety and efficacy. Platelet-rich plasma is emerging as a possible add-on treatment…
Former Heart Institute dean highlights sedentary lifestyles and excess visceral fat as major health threats, advocating daily walking and lifestyle changes to reduce cardiovascular risks. Obesity is no longer just a question of appearance or excess body weight. It is…
While both forms of diabetes lead to high blood glucose, emerging research highlights distinct causes, symptoms, and management strategies, underscoring the importance of accurate diagnosis and personalised treatment. Diabetes is among the most common long-term illnesses, yet the condition is…
Researchers at the University of Florida have identified a population of stem-like immune cells in pancreatic lymph nodes that could explain ongoing autoimmune destruction in type 1 diabetes, opening new avenues for potential therapies. Researchers at the University of Florida…
Novo Nordisk has introduced Ozempic and Wegovy to Kenya, aiming to tackle escalating rates of type 2 diabetes and obesity. Experts highlight challenges like underdiagnosis and affordability that could influence the real impact of these new treatments in the African…
The global diabetes management app market is forecasted to grow from $1.71 billion in 2025 to $15.53 billion by 2035, driven by automation, AI insights, and integrated care platforms, with North America leading expansion and Asia-Pacific emerging rapidly. The diabetes…
Encellin has teamed up with Breakthrough T1D to advance its immune-protected cell therapy programme, securing $2.5 million funding to propel clinical development of a novel implant designed to shield insulin-producing cells from immune rejection in type 1 diabetes patients. Encellin…
A Corpus Christi couple has arranged a partnership with Mattel to deliver up to 10,000 Barbie dolls designed to reflect the reality of children with Type 1 diabetes, aiming to inspire inclusion and awareness nationwide. John and Cheryl Navar, a…
As Jeanne Shaheen nears the end of her Senate tenure, a cross-party effort gains momentum to limit insulin out-of-pocket costs amid soaring prices and public health concerns. As her Senate career draws to a close, Jeanne Shaheen is making one…
Genentech’s experimental drug enicepatide achieved significant blood sugar and weight loss reductions in a phase II trial, signalling potential new options in the competitive obesity and diabetes treatment market. Genentech said its experimental diabetes and obesity drug enicepatide met both…
